10 Alabama Health Care facilities received NECC products

By  | October 12, 2012 | Filed under: News

MONTGOMERY – Although no Alabama health care facilities received fungus-contaminated injections from New England Compounding Center, 10 health care facilities did receive other NECC sterile injectable products. The compounding pharmacy is at the center of a massive multi-state fungal meningitis outbreak.

 

 

 

 

 

The fungus Exserohilum has been implicated in the current outbreak of fungal meningitis.

The Alabama Department of Public Health has contacted all facilities in the state and they have been instructed to immediately stop using the medicine. All clinics, hospitals and health care providers that have the recalled product have been instructed  by ADPH to retain and secure it, and contact NECC.

 

 

 

 

 

 

 

Dr. Mary McIntyre, Alabama Department of Public Health

Dr. Mary McIntyre, acting state epidemiologist for ADPH, stated, “As the 23 states contact all patients (up to 14,000) who received one of the three contaminated lots of methylprednisolone acetate (a steroid), Alabama residents who received treatment in other states may be involved and contacted by their health care provider or public health. As the ongoing investigation expands to more products, this increases the possibility that Alabama residents received NECC products.”

 

 

 

 

 

 

 

No fungal meningitis cases have been found in Alabama in this outbreak.

At this time there is no evidence to indicate that products other than the three initial NECC lots are contaminated. There is also no evidence at this time that any of the NECC products received by Alabama’s facilities are contaminated. Other manufacturers’ products are not involved in this investigation, and medically necessary care should not be delayed out of fear that patients will receive an NECC product. All NECC products have been recalled. 

A Health Alert Network message will be sent to all physicians to let them know about the products recalled and what to do with patients who present with symptoms. This type of meningitis is not contagious, and it cannot be spread from person to person. The symptoms include fever, headache (new symptoms or worsening), onset of stiff neck or sensitivity to light, or symptoms suggestive of a stroke such as slurred speech, difficulty walking, or increased dizziness or falls. 

Alabama residents who have had an epidural steroid injection since May 21, 2012, and have any of the following symptoms, should talk to their doctor as soon as possible:
·        New or worsening headache
·        Fever
·        Sensitivity to light
·        Stiff neck
·        New weakness or numbness in any part of your body
·        Slurred speech
·        Increased pain, redness or swelling at your injection site

Additional information, including a list of states involved, is available at
http://www.cdc.gov/hai/outbreaks/meningitis.html.

Print Friendly, PDF & Email

One Response to 10 Alabama Health Care facilities received NECC products

  1. Rosedale Gardens October 12, 2012 at 11:33 pm

    Aspergillus has been isolated also.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

NWS_CC Bank Independent
Helen Keller Hospital Coldwater Inn

Music Weekend

Champy's 306 Barbecue OTR